[go: up one dir, main page]

MXPA00007394A - Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases. - Google Patents

Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases.

Info

Publication number
MXPA00007394A
MXPA00007394A MXPA00007394A MXPA00007394A MXPA00007394A MX PA00007394 A MXPA00007394 A MX PA00007394A MX PA00007394 A MXPA00007394 A MX PA00007394A MX PA00007394 A MXPA00007394 A MX PA00007394A MX PA00007394 A MXPA00007394 A MX PA00007394A
Authority
MX
Mexico
Prior art keywords
compositions
treating
compounds
methods
associated diseases
Prior art date
Application number
MXPA00007394A
Other languages
Spanish (es)
Inventor
J Nitz Theodore
Original Assignee
Viropharma Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Viropharma Inc filed Critical Viropharma Inc
Publication of MXPA00007394A publication Critical patent/MXPA00007394A/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12Antivirals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D249/00Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms
    • C07D249/02Heterocyclic compounds containing five-membered rings having three nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D249/081,2,4-Triazoles; Hydrogenated 1,2,4-triazoles
    • C07D249/101,2,4-Triazoles; Hydrogenated 1,2,4-triazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D249/14Nitrogen atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D257/00Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms
    • C07D257/02Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms not condensed with other rings
    • C07D257/04Five-membered rings
    • C07D257/06Five-membered rings with nitrogen atoms directly attached to the ring carbon atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D261/00Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings
    • C07D261/02Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings
    • C07D261/06Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members
    • C07D261/08Heterocyclic compounds containing 1,2-oxazole or hydrogenated 1,2-oxazole rings not condensed with other rings having two or more double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D277/00Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings
    • C07D277/02Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings
    • C07D277/20Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
    • C07D277/22Heterocyclic compounds containing 1,3-thiazole or hydrogenated 1,3-thiazole rings not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
    • C07D277/24Radicals substituted by oxygen atoms

Landscapes

  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Communicable Diseases (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pyrrole Compounds (AREA)
  • Heterocyclic Compounds Containing Sulfur Atoms (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Furan Compounds (AREA)
  • Pyridine Compounds (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
  • Plural Heterocyclic Compounds (AREA)
MXPA00007394A 1998-01-29 1999-01-29 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases. MXPA00007394A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US7303898P 1998-01-29 1998-01-29
US7307898P 1998-01-30 1998-01-30
PCT/US1999/001985 WO1999038508A1 (en) 1998-01-29 1999-01-29 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases

Publications (1)

Publication Number Publication Date
MXPA00007394A true MXPA00007394A (en) 2003-08-01

Family

ID=26754055

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA00007394A MXPA00007394A (en) 1998-01-29 1999-01-29 Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases.

Country Status (9)

Country Link
EP (1) EP1051169A4 (en)
JP (1) JP2002501894A (en)
CN (1) CN1289248A (en)
AU (1) AU759772B2 (en)
BR (1) BR9908522A (en)
CA (1) CA2319465C (en)
MX (1) MXPA00007394A (en)
NZ (1) NZ505894A (en)
WO (1) WO1999038508A1 (en)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6489338B2 (en) 2000-06-13 2002-12-03 Bristol-Myers Squibb Company Imidazopyridine and imidazopyrimidine antiviral agents
CN100560131C (en) 2001-10-22 2009-11-18 斯克里普斯研究学院 Antibody targeting compounds
CA2495266A1 (en) * 2002-08-09 2004-02-19 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
AU2003258177A1 (en) 2002-08-09 2004-02-25 Viropharma Incorporated Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
EP1682547B1 (en) 2003-10-30 2012-10-24 Boehringer Ingelheim (Canada) Ltd. Rsv polymerase inhibitors
US8247576B2 (en) 2003-12-23 2012-08-21 Astex Therapeutics Limited Pyrazole derivatives as protein kinase modulators
WO2006136821A1 (en) 2005-06-22 2006-12-28 Astex Therapeutics Limited Pharmaceutical compounds
JP5345842B2 (en) 2005-06-23 2013-11-20 アステックス・セラピューティクス・リミテッド Pharmaceutical combinations containing pyrazole derivatives as protein kinase modulators
GB0704932D0 (en) 2007-03-14 2007-04-25 Astex Therapeutics Ltd Pharmaceutical compounds
JP2012517447A (en) 2009-02-10 2012-08-02 ザ スクリプス リサーチ インスティチュート Chemically programmed vaccination methods
EP2867216A4 (en) * 2012-06-29 2015-12-09 Microdose Therapeutx Inc Compositions and methods for treating or preventing pneumovirus infection and associated diseases
EP3081569B1 (en) 2013-12-10 2019-09-18 Shandong Danhong Pharmaceutical Co., Ltd. Imidazole derivative used as antiviral agent and use thereof in preparation of medicament
JP6548751B2 (en) 2015-06-08 2019-07-24 シャンドン ダンホン ファーマスーティカル カンパニー リミテッドShandong Danhong Pharmaceutical Co., Ltd. Preparation and crystal form of imidazole derivative and its intermediate
WO2020252396A1 (en) * 2019-06-13 2020-12-17 Cidara Therapeutics, Inc. Compositions and methods for the treatment of respiratory syncytial virus

Family Cites Families (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1508391A (en) * 1975-01-20 1978-04-26 Sterling Drug Inc Phenylalkylamines
US4324794A (en) * 1980-08-26 1982-04-13 Research Triangle Institute Inhibition of respiratory syncytial virus-induced cell fusion by amidino compounds
US5098920A (en) * 1990-05-04 1992-03-24 G. D. Searle & Co. 1h-substituted-1,2,4-triazole compounds and methods of use thereof for treatment of cardiovascular disorders
EP0714292A4 (en) * 1993-06-23 1996-10-09 Cambridge Neuroscience Inc Sigma receptor ligands and the use thereof
AU6475696A (en) * 1995-07-27 1997-02-26 Warner-Lambert Company Substituted phenols as novel calcium channel blockers
CN1163401A (en) * 1996-02-13 1997-10-29 李占元 Fully automatic hemacytometer reagent and preparing method
CA2250464A1 (en) * 1996-03-29 1997-10-09 G.D. Searle & Co. Meta-substituted phenylene derivatives and their use as alphavbeta3 integrin antagonists or inhibitors

Also Published As

Publication number Publication date
CN1289248A (en) 2001-03-28
CA2319465A1 (en) 1999-08-05
JP2002501894A (en) 2002-01-22
NZ505894A (en) 2002-12-20
BR9908522A (en) 2001-10-02
AU759772B2 (en) 2003-05-01
EP1051169A1 (en) 2000-11-15
EP1051169A4 (en) 2002-05-29
CA2319465C (en) 2013-03-19
WO1999038508A1 (en) 1999-08-05

Similar Documents

Publication Publication Date Title
EP1128832A4 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
EP1109580A4 (en) Methods for treating or preventing viral infections and associated diseases
EP1115286A4 (en) Methods for treating or preventing viral infections and associated diseases
MX264033B (en) Enzyme treatment for infection.
ZA200004956B (en) Vaccine composition.
MX221888B (en) Pesticidal composition for seed treatment.
WO2001017543A3 (en) Compositions and methods for the prevention or treatment of cancer and bone loss associated with cancer
ZA200108912B (en) Attenuated microorganisms for the treatment of infection.
ZA200108215B (en) Compositions and methods for treatment of staphylococcal infection.
MXPA00007394A (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases.
EP0920419A4 (en) Compounds, compositions and methods for treating influenza
AU3896899A (en) Compositions for the treatment of tumors, and uses thereof
ZA200203435B (en) Method and compositions for treating pulmonary diseases.
ZA200109845B (en) Hair treatment compositions.
AU2003258176A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
GB9815312D0 (en) Biomas treatment
GB9917593D0 (en) Compound, composition, process and use
PL345068A1 (en) Novel compounds derived from α-d-xylose, preparation method and therapeutic use
ZA200002546B (en) Sorbate-preserved compositions, method for the manufacture thereof and their use.
AU2003237088A8 (en) Compounds, compositions and methods for treating or preventing viral infections and associated diseases
AU6798000A (en) Compounds, compositions and methods for treating influenza
ZA99253B (en) Treatment of waxes.
AU2003258177A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
HK1029938A (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
ZA200007396B (en) Method of treatment.